Do you need both Prevnar 13 and Pneumovax 23

ACIP recommends that both PCV13 and PPSV23 be given in series to adults aged ≥65 years. A dose of PCV13 should be given first followed by a dose of PPSV23 at least 1 year later to immunocompetent adults aged ≥65 years. The two vaccines should not be co-administered.

Do I need Prevnar 13 if I had Pneumovax 23?

In some cases, the CDC recommends that adults get Prevnar 13 in addition to Pneumovax 23. If a person has any of the following conditions, they are considered at high risk for a serious pneumococcal infection, and need both vaccines: A cerebrospinal fluid leak. A cochlear implant.

Do you need two pneumonia shots?

If you or a loved one is age 65 or older, getting vaccinated against pneumonia is a good idea — so good that the Centers for Disease Control (CDC) now recommends that everyone in this age group get vaccinated against pneumonia twice.

Do you give Prevnar 13 or 23 first?

PCV13 and PPSV23 should not be administered during the same office visit. When both are indicated, PCV13 should be given before PPSV23 whenever possible. If either vaccine is inadvertently given earlier than the recommended window, do not repeat the dose.

When do you give Prevnar 13 and Pneumovax 23?

Give 1 dose of PCV13 first. Give 1 dose of PPSV23 at least 8 weeks after any prior PCV13 dose and at least 5 years after any prior PPSV23 dose. Anyone who received any doses of PPSV23 before age 65 should receive 1 final dose of the vaccine at age 65 or older.

Is Prevnar 13 good for life?

Prevnar 13 shot may no longer be necessary for healthy adults over 65. En español | While pneumococcal disease is often mild, it can sometimes have serious and even deadly repercussions for those 65 years or older — particularly when the bacteria that causes it invade the lungs, causing pneumonia.

Why is Prevnar no longer recommended?

Specific underlying medical conditionChronic lung disease¶PCV13 for persons aged ≥19 yearsNo recommendationPPSV23* for persons aged 19–64 years1 dosePCV13 for persons aged ≥65 yearsBased on shared clinical decision-making†

How many doses of Prevnar 13 are needed?

Prevnar 13 is to be administered as a four-dose series at 2, 4, 6, and 12-15 months of age. a Dose 1 may be given as early as 6 weeks of age. b The recommended dosing interval is 4 to 8 weeks. c The fourth dose should be administered at approximately 12-15 months of age, and at least 2 months after the third dose.

How many doses of Prevnar 13 are needed for adults?

CDC recommends some adults receive up to 3 doses of PPSV23 in a lifetime. Adults who have immunocompromising conditions should receive two doses of PPSV23, given 5 years apart, before age 65 years.

What is the difference between pneumococcal 13 and 23?

Prevnar 13 protects against 13 types of bacteria, and Pneumovax 23 protects against 23 types of bacteria. Prevnar 13 is given in the muscle (IM), while Pneumovax 23 can be given either in the muscle (IM) or under the skin (subcutaneously). Most adults over 65 will receive one dose of each vaccine, one year apart.

Article first time published on

Is Prevnar 13 still recommended for adults?

PCV13 vaccination is no longer routinely recommended for all adults age >65 years. Instead, shared clinical decision-making for PCV13 use is recommended for persons age >65 years who do not have an immunocompromising condition, CSF leak, or cochlear implant and who have not previously received PCV13.

Who needs Prevnar 13 vaccine?

CDC recommends pneumococcal vaccination for all children younger than 2 years old and all adults 65 years or older. In certain situations, older children and other adults should also get pneumococcal vaccines.

Why do adults need Prevnar 13?

PREVNAR 13® is a vaccine approved for adults 50 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by the 13 Streptococcus pneumoniae strains included in the vaccine.

Is Prevnar 13 required?

Pneumococcal conjugate vaccine (PCV13, Prevnar 13, Pfizer) is recommended for all adults without a prior PCV13 vaccination who have a high-risk condition, including immunocompromising conditions, cerebrospinal fluid (CSF) leak, and cochlear implant.

Who should get Prevnar 23?

PNEUMOVAX 23 is recommended by the CDC for people 65 years or older — even if they may have already received a dose of another vaccine for pneumococcal disease. It is also recommended for adults 19 to 64 years of age who have certain chronic conditions (diabetes, heart disease, or COPD).

Do you need 2 doses of Prevnar 13?

Prevnar 13 is to be administered as a four-dose series at 2, 4, 6, and 12–15 months of age. Dose 1 may be given as early as 6 weeks of age. The recommended dosing interval is 4 to 8 weeks. The fourth dose should be administered at approximately 12–15 months of age, and at least 2 months after the third dose.

When do you give Pneumovax vs Prevnar?

For immunocompetent adult patients aged ≥65 years with CSF leak or cochlear implant, the CDC recommends a routine dose of Prevnar 13 (if not previously received) followed at least 8 weeks later by a routine dose of PNEUMOVAX 23.

How long does Prevnar 13 protection last?

It also helps prevent the spread of the infection from person to person. The vaccine’s protection lasts at least 3 years. The most serious pneumococcal infections happen during the first 2 years of life. This means the vaccine protects children when they are at the greatest risk.